Gilead Sciences Inc (GILD)

65.68 -0.49 (-0.74%)
Closed USD Disclaimer
65.65 -0.03 (-0.05%)

Gilead Sciences Inc Company Profile

Industry
Pharmaceuticals
Sector
Healthcare
Employees
18000
Equity Type
ORD
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, Sunlencs, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of COVID-19; and Epclusa, Harvoni, Vemlidy, and Viread for the treatment of viral hepatitis. It also offers Yescarta, Tecartus, and Trodelvy products for the treatment of oncology; Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. The company has collaboration agreements with Arcus Biosciences, Inc.; Merck Sharp & Dohme Corp.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Dragonfly Therapeutics, Inc.; Arcellx, Inc.; Everest Medicines; Merck & Co, Inc.; Tentarix Biotherapeutics Inc.; and Assembly Biosciences, Inc. It also has research collaboration, option, and license agreement with Merus N.V. for the discovery of novel dual tumor-associated antigens (TAA) targeting trispecific antibodies. The company was incorporated in 1987 and is headquartered in Foster City, California.
Contact Information
Address
Foster City,94404 United States
Phone
650 574 3000
Fax
650 578 9264
Top Executives
Name
Age
Since
Title
Daniel P. O'Day 57 2019 Chairman & CEO
Paul Berg 97 1998 Member of Scientific Advisory Board
Grace E. Colon 56 2023 Chairman of the Board
Joel R. Huff 0 0000 Chairperson of Scientific Advisory Board
Kelly A. Kramer 56 2016 Independent Director
Javier J. Rodriguez 53 2020 Independent Director
Sandra J. Horning 75 2020 Independent Director
Jeffrey A. Bluestone 71 2020 Independent Director
Ted W. Love 65 2024 Independent Director
Jacqueline K. Barton 71 1989 Independent Director
Eugene R. Schiff 0 0000 Member of the Scientific Advisory Board
John W. Mellors 86 0000 Member of the Scientific Advisory Board
Harish M. Manwani 71 2018 Independent Director
Eric J. Topol 70 0000 Member of Scientific Advisory Board
Robert A. Harrington 63 0000 Member of the Scientific Advisory Board
Paul E. Klotman 0 0000 Member of the Scientific Advisory Board
Francis V. Chisari 0 0000 Member of the Scientific Advisory Board
Robert T. Schooley 0 0000 Member of the Scientific Advisory Board
Nezam H. Afdhal 67 0000 Member of Scientific Advisory Board
Mark C. Genovese 0 0000 Member of Scientific Advisory Board
Malcolm MacCoss 76 0000 Member of Scientific Advisory Board
Anthony Welters 69 2020 Lead Independent Director
Kenneth C. Anderson 73 0000 Member of the Scientific Advisory Board
Brian J. Druker 68 0000 Member of the Scientific Advisory Board
Clear All
0Selected
Please try another search

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.